New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of a new retrospective analysis, conducted in partnership with Duke Health, that found incorporating ECG data from long-term continuous monitoring can more accurately predict heart failure hospitalization compared to clinical history or risk scores alone. This data was presented at the American Heart Association’s (AHA) 2023 Scientific Sessions in Philadelphia held November 11-13.
Related news for (IRTC)
- iRhythm Technologies Announces First Quarter 2025 Financial Results
- iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results
- iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference
- irhythm technologies announces third quarter 2024 financial results
- irhythm technologies enters license agreement with biointellisense for multiparameter sensor technology to be used in ambulatory cardiac monitoring